The Pistoia Alliance, a global not-for-profit alliance, announced results of a survey of 229 life science professionals. The survey indicated that the majority (72%) believe their sector is lagging behind other industries in its AI development.
The survey found adoption of AI is high, with more than two thirds (69%) of companies using AI, machine learning, deep learning, and chatbots; an increase from when the same question was asked last September, where under half (44%) of respondents were using or experimenting with AI. A further 19% of respondents signaled that they plan to use AI within the next 12 months, with just 12% of life science professionals not using AI at all. Of those currently using AI in their organizations, approximately a fifth (21%) felt that their projects were not yet providing meaningful outcomes, and 21% ‘didn’t know’ if projects were delivering meaningful outcomes. The Pistoia Alliance believes collaboration between interested parties will be essential in ensuring AI projects lead to results that positively impact R&D.
Additionally, The Pistoia Alliance has launched its Centre of Excellence for AI in Life Sciences to accelerate the successful use of AI. The Centre of Excellence aims to help facilitate these collaborations by allowing companies to share their expertise and knowledge, in addition to holding events that help organizations build prototypes and pilots that prove the value of AI.
The survey of 229 senior pharmaceutical and life science leaders was conducted via webinar in May 2018. For information and slides from the webinars, see here.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Beyond the Prescription: The Role Pharma Plays in Digital Health Conversations
April 1st 2025As social media continues to influence healthcare communication, it presents both challenges and opportunities for the pharmaceutical industry. In this interview, Jennifer Harakal of Canopy Life Sciences discusses balancing compliance with effective digital engagement to build trust and facilitate meaningful healthcare conversations.